BioDelivery Sciences International (BDSI)

NASDAQ
3.360
+0.180(+5.66%)
After Hours
3.360
0.000(0.00%)
- Real-time Data
  • Volume:
    3,835,121
  • Bid/Ask:
    3.340/3.460
  • Day's Range:
    3.140 - 3.549

BDSI Overview

Prev. Close
3.18
Day's Range
3.14-3.549
Revenue
165.72M
Open
3.15
52 wk Range
2.5-4.675
EPS
0.3
Volume
3,835,121
Market Cap
331.95M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,535,063
P/E Ratio
10.61
Beta
0.82
1-Year Change
-18.84%
Shares Outstanding
98,795,939
Next Earnings Date
Mar 17, 2022
What is your sentiment on BioDelivery Sciences International?
or
Market is currently closed. Voting is open during market hours.

BioDelivery Sciences International Company Profile

Employees
176

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company focuses on delivering therapies for individuals living with serious and debilitating chronic conditions. The Compnay builts a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA), drug-delivery technology to develop and commercialize new applications of therapies aimed at addressing important unmet medical needs. BEMA drug delivery technology consists of a small, bi-layered erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's product candidates includes BELBUCA (buprenorphine buccal film), CIII, for Chronic Pain; Symproic (naldemedine), for Opioid Induced Constipation and ONSOLIS (fentanyl buccal soluble film) for Breakthrough Cancer Pain.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuySell
Technical IndicatorsBuySellStrong BuyStrong BuyStrong Sell
SummaryBuyNeutralStrong BuyStrong BuyStrong Sell
  • After 3 weeks of consolidation, the price is no lower than $3, so it will soon challenge $3.5 again.
    0
    • very good arrow
      0
      • Buy now for 2.68 USD and wait for two months to reach 3.3~3.5 USD
        1
        • on point, it just took 2 weeks haha
          0
      • The current technical condition of BDSI is deteriorating, indicating demand for the stock is weakening. If momentum continues to slow, further slippage in the stock is likely to develop. The stock is underperforming the market when compared to the S&P 500 over the last 50 trading days. The MACD-LT, an intermediate-term trend indicator, is bearish at this time. BDSI's chart formation is showing signs of reversing its recent trend. If the stock closes below $3.43 a change in trend will be confirmed. Upside momentum, as measured by the 9-day RSI, is negative. Over the last 50 trading sessions, there has been more volume on up days than on down days, indicating that BDSI is under accumulation. The stock is trading below a falling 50-day moving average which confirms the deteriorating technical condition of BDSI. In addition, BDSI is below its declining 200-day moving average
        0
        • 4.3$ by 16/4.
          0
          • Today 14th Jan somebody has bought 4 million!! Time to buy, for sure!
            0
            • It seems to be a change of shares adquisition-delivery with no impact on the price. So forget it
              0
          • Get in now rocket 🚀
            0
            • this is a slow moving stock.i do rather investsomewhere else.
              0
              • is it worth to entry now in BioDelivery Sciences International BDSI ?
                0
                • It has potential to upto 12 $. They have huge amount of cash flow. let's see If it continues this quarterly.. Really good buy at 3.52$ for next 1 month.
                  0
                  • HELLO hello Mr. Patel., do you think from next week Monday we have to buy some ? to entry in this stock ?
                    0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.